| Literature DB >> 29173673 |
William F Dresen1, John D Ferguson2.
Abstract
Ventricular tachycardia (VT) is the most common form of wide complex tachycardia and is associated with a high mortality rate. Electrocardiographic analysis remains paramount in diagnosis and helps to direct therapy. Antiarrhythmic agents, although effective in reducing arrhythmia burden, have never demonstrated a mortality benefit. The implantable cardioverter-defibrillator aids not only in the acute termination of ventricular arrhythmia, but provides a wealth of information for the long-term management of patients with VT. Contemporary treatment options such as catheter ablation are increasingly used and effective, but often remain imperfect, with recurrent VT being not uncommon.Entities:
Keywords: Catheter ablation; Implantable cardioverter-defibrillator; Ventricular fibrillation; Ventricular tachycardia
Mesh:
Year: 2017 PMID: 29173673 DOI: 10.1016/j.ccl.2017.08.007
Source DB: PubMed Journal: Cardiol Clin ISSN: 0733-8651 Impact factor: 2.213